13 May 2024AmericasMarisa Woutersen

LSPN Spring: Section 101 uncertainty ‘impacts US prosecution’

As Congress considers the Patent Eligibility Restoration Act of 2023, experts from NeoGenomics, Biogen, and Choate Hall & Stewart at LSPN Spring weigh in on its potential effect and the need for further clarification to improve patent eligibility standards.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Boston to host biggest LSPN North America–Spring Conference

7 May 2024 Two-day event in Boston brings together leading in-house patent counsel | Regeneron, USPTO, the Broad Institute and Novartis among attendees I Agenda includes the UPC, patent strategies, and multijurisdictional patent litigation | Registrations for LSPN Fall now open.

LSPN Spring: Preliminary injunctions ‘a focal point’ in UPC decisions

9 May 2024 A significant uptake in unitary patents show court is here “in a big way” | Speakers shed light on the UPC's approach to preliminary injunctions and evidence gathering at LSPN Spring in Boston.

More on this story

Boston to host biggest LSPN North America–Spring Conference

7 May 2024 Two-day event in Boston brings together leading in-house patent counsel | Regeneron, USPTO, the Broad Institute and Novartis among attendees I Agenda includes the UPC, patent strategies, and multijurisdictional patent litigation | Registrations for LSPN Fall now open.

LSPN Spring: Preliminary injunctions ‘a focal point’ in UPC decisions

9 May 2024 A significant uptake in unitary patents show court is here “in a big way” | Speakers shed light on the UPC's approach to preliminary injunctions and evidence gathering at LSPN Spring in Boston.

More on this story

Boston to host biggest LSPN North America–Spring Conference

7 May 2024 Two-day event in Boston brings together leading in-house patent counsel | Regeneron, USPTO, the Broad Institute and Novartis among attendees I Agenda includes the UPC, patent strategies, and multijurisdictional patent litigation | Registrations for LSPN Fall now open.

LSPN Spring: Preliminary injunctions ‘a focal point’ in UPC decisions

9 May 2024 A significant uptake in unitary patents show court is here “in a big way” | Speakers shed light on the UPC's approach to preliminary injunctions and evidence gathering at LSPN Spring in Boston.

More features

Bayer gains exclusive licence for heart drug in Japan

EPO delivers key Novo Nordisk, GSK and Inhibrx rulings

McGuireWoods expands team with ex-Novo Nordisk GC

Paul, Weiss swoops for senior duo from Weil, Gotshal

UPC bans Meril Life Sciences from selling infringing heart valve

SCOTUS denies Alvogen unit's appeal to sell Bausch Xifaxan generic

Kathi Vidal to rejoin previous firm as partner following USPTO departure

GSK triumphs in EPO appeal, revoking Pfizer patent